Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02673372 · ClinicalTrials.gov registry record · Phase 4
Geriatric Ketamine for Pain Management Study
A Phase 4 study, sponsored by Antonios Likourezos.
- Completed
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
NCT02673372 is a Phase 4 study that has completed, run by Antonios Likourezos. The registered enrollment target is 60 participants.
The verdict
NCT02673372, a Phase 4 study, has completed, sponsored by Antonios Likourezos.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
Study Summary
This research project is geared towards geriatric analgesia in the Emergency Department (ED) with a goal of reducing the administration of opioid pain medications to elderly patients, thereby avoiding the commonly occurring, severe side effects associated with such medications, including hypotension, respiratory depression, altered mental status, delirium, as well as nausea/vomiting and constipation. The primary outcome of the study will be difference in pain score from baseline to 30 minutes post-medication administration. This project has the potential to change and modify the ED approach to geriatric analgesia by virtue of minimizing the use of opioid administration in elderly patients. T
Interventions
- DRUG Ketamine
- DRUG Morphine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2016-04 |
| Est. Completion | 2018-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02673372
The ClinicalTrials.gov registry entry for NCT02673372 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Antonios Likourezos, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ketamine is the first listed.
NCT02673372 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02673372 about?
NCT02673372 is a clinical study titled "Geriatric Ketamine for Pain Management Study". This research project is geared towards geriatric analgesia in the Emergency Department (ED) with a goal of reducing the administration of opioid pain medications to elderly patients, thereby avoiding the commonly occurring, severe side effects associated with such medications, including hypotension...
What is the current status of trial NCT02673372?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2016-04. Estimated completion is 2018-04.
What interventions are being tested in trial NCT02673372?
The interventions under investigation include: Ketamine (DRUG), Morphine (DRUG).
Who is sponsoring clinical trial NCT02673372?
This trial is sponsored by Antonios Likourezos, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.